Standout Papers
Immediate Impact
2 by Nobel laureates 5 from Science/Nature 58 standout
Citing Papers
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Works of Z. Gordon Jiang being referenced
Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Z. Gordon Jiang | 672 | 403 | 324 | 328 | 87 | 1.5k | |
| K Kozaki | 236 | 308 | 338 | 641 | 57 | 1.5k | |
| Gadi Lalazar | 857 | 442 | 660 | 230 | 61 | 1.9k | |
| Tim Hendrikx | 785 | 182 | 648 | 296 | 39 | 1.6k | |
| Rita Carini | 367 | 362 | 609 | 516 | 58 | 1.9k | |
| Monika Rau | 1053 | 374 | 541 | 214 | 43 | 1.7k | |
| Leila Gobejishvili | 906 | 256 | 975 | 159 | 55 | 2.1k | |
| Liang Xu | 949 | 279 | 643 | 370 | 67 | 2.1k | |
| Xiaofeng Fan | 546 | 452 | 655 | 168 | 91 | 2.2k | |
| Shvetank Sharma | 990 | 322 | 554 | 246 | 46 | 1.5k | |
| Sameh Saber | 307 | 166 | 921 | 201 | 112 | 2.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...